Vimarsana
Biggest News Aggregation in the World

Angela Schulz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Angela Schulz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Angela Schulz Today - Breaking & Trending Today

The Sweat Box in Mentor offers welcoming fitness opportunities for 'everyBODY' - Vimarsana News

The Sweat Box in Mentor offers welcoming fitness opportunities for 'everyBODY'

The Sweat Box is a group fitness studio where the motto is “everyBODY” is celebrated and welcome. Everybody who enjoys Casey Vanac’s Mentor gym and staff is now going to be welcomed in a new location. After opening at Garfield Park in 2021, The Sweat Box has moved to 8920 Mentor Ave. – Unit H, […]

MSUM's summer theater company Straw Hat Players is ready to celebrate its 60th anniversary in 'Grand' fashion - Vimarsana News

MSUM's summer theater company Straw Hat Players is ready to celebrate its 60th anniversary in 'Grand' fashion

The summer lineup opens May 30 with a musical revue of Rodgers and Hammerstein.

BioMarin Pharmaceutical commemorates 5 years of helping children with fatal rare disease - Vimarsana News

BioMarin Pharmaceutical commemorates 5 years of helping children with fatal rare disease

After losing one child to the rare Batten disease, the Bowmans turned to the Marin County biopharmaceutical company, to treat their other kids with the drug Brineura.

Beyond Batten Disease Foundation Announces Agreement with Actelion [...] - Vimarsana News

Beyond Batten Disease Foundation Announces Agreement with Actelion [...]

02 marzo 2021 17:14 Fonte: Adnkronos #salute-e-benessere AUSTIN, Texas, March 2, 2021 /PRNewswire/ -- Beyond Batten Disease Foundation (BBDF) is pleased to announce an agreement with Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson, to provide Zavesca® (miglustat) for the development of BBDF-101, a proprietary combination of miglustat and trehalose to treat juvenile Batten disease (CLN3). Janssen will provide drug supply for the clinical trials and Extended Access Program, and right of reference to data within the Zavesca New Drug Application (NDA) to sup...